Edurant Ped Tablet, For Suspension
Product Images NDC 59676-280

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Edurant Ped (NDC 59676-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Edurant 01)

Chemical Structure (Edurant 01)
Chemical structure of rilpivirine hydrochloride, the active ingredient in EDURANT PED tablets for suspension.*
FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

Principal Display Panel (25 mg Tablet Bottle Label)
EDURANT 25 mg (rilpivirine) tablets packaging label for oral tablet dosage form. The label shows 30 tablets per package, with each tablet containing 25 mg rilpivirine equivalent. It includes a caution alert about medicines not to be taken with EDURANT and states Rx only. The label identifies Janssen Products, LP as the labeler and includes NDC 59676-278-01. Additional manufacturing details and storage instructions are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.